Sertraline induced severe neutropenia: An adolescent case with the Guillain-Barre Syndrome

Creative Commons License

Akcay E., YALÇIN Ö.

KLINIK PSIKIYATRI DERGISI-TURKISH JOURNAL OF CLINICAL PSYCHIATRY, cilt.24, sa.3, ss.413-415, 2021 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 24 Sayı: 3
  • Basım Tarihi: 2021
  • Doi Numarası: 10.5505/kpd.2021.42650
  • Dergi Adı: KLINIK PSIKIYATRI DERGISI-TURKISH JOURNAL OF CLINICAL PSYCHIATRY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, Psycinfo, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.413-415
  • Anahtar Kelimeler: Neutropenia, Agranulocytosis, Sertraline, Antidepressants, Drug-Related Side Effects and Adverse Reactions
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • Ankara Üniversitesi Adresli: Evet

Özet

Neutropenia, which is defined as a neutrophil count below 1500/ml, is a rare but potentially life-threatening side effect of psychotropic drugs. Neutropenia associated with sertraline, which is a selective serotonin reuptake inhibitor (SSRI) antidepressant, has been reported in only five case reports so far. We report a 16-year-old adolescent male diagnosed with Guillain-Barre Syndrome who developed severe neutropenia during treatment with sertraline for his depressive and anxious symptoms.